154 related articles for article (PubMed ID: 24938380)
1. Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children's Cancer Study Group (TCCSG) clinical trials.
Kato M; Manabe A; Koh K; Inukai T; Kiyokawa N; Fukushima T; Goto H; Hasegawa D; Ogawa C; Koike K; Ota S; Noguchi Y; Kikuchi A; Tsuchida M; Ohara A
Int J Hematol; 2014 Aug; 100(2):180-7. PubMed ID: 24938380
[TBL] [Abstract][Full Text] [Related]
2. Outcome of pediatric acute lymphoblastic leukemia with very late relapse: a retrospective analysis by the Tokyo Children's Cancer Study Group (TCCSG).
Kato M; Manabe A; Saito AM; Koh K; Inukai T; Ogawa C; Goto H; Tsuchida M; Ohara A
Int J Hematol; 2015 Jan; 101(1):52-7. PubMed ID: 25432437
[TBL] [Abstract][Full Text] [Related]
3. Improved prognosis for older adolescents with acute lymphoblastic leukemia.
Pui CH; Pei D; Campana D; Bowman WP; Sandlund JT; Kaste SC; Ribeiro RC; Rubnitz JE; Coustan-Smith E; Jeha S; Cheng C; Metzger ML; Bhojwani D; Inaba H; Raimondi SC; Onciu M; Howard SC; Leung W; Downing JR; Evans WE; Relling MV
J Clin Oncol; 2011 Feb; 29(4):386-91. PubMed ID: 21172890
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic bone marrow transplantation in first remission rescues children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) studies L89-12 and L92-13.
Mori T; Manabe A; Tsuchida M; Hanada R; Yabe H; Ohara A; Saito T; Nakazawa S
Med Pediatr Oncol; 2001 Nov; 37(5):426-31. PubMed ID: 11745870
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
7. Pediatric randomized trial EORTC CLG 58951: Outcome for adolescent population with acute lymphoblastic leukemia.
Olivier-Gougenheim L; Arfeuille C; Suciu S; Sirvent N; Plat G; Ferster A; de Moerloose B; Domenech C; Uyttebroeck A; Rohrlich PS; Cavé H; Bertrand Y
Hematol Oncol; 2020 Dec; 38(5):763-772. PubMed ID: 32809224
[TBL] [Abstract][Full Text] [Related]
8. Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia.
Fathi AT; DeAngelo DJ; Stevenson KE; Kolitz JE; Asch JD; Amrein PC; Attar EC; Steensma DP; Wadleigh M; Foster J; Connolly C; Galinsky I; Devoe CE; Stone RM; Neuberg DS; Ballen KK
Cancer; 2016 Aug; 122(15):2379-88. PubMed ID: 27171984
[TBL] [Abstract][Full Text] [Related]
9. Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study.
Testi AM; Attarbaschi A; Valsecchi MG; Möricke A; Cario G; Niggli F; Silvestri D; Bader P; Kuhlen M; Parasole R; Putti MC; Lang P; Flotho C; Mann G; Rizzari C; Barisone E; Locatelli F; Linderkamp C; Lauten M; Suttorp M; Zimmermann M; Basso G; Biondi A; Conter V; Schrappe M;
Eur J Cancer; 2019 Nov; 122():61-71. PubMed ID: 31629941
[TBL] [Abstract][Full Text] [Related]
10. Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
Spinelli O; Peruta B; Tosi M; Guerini V; Salvi A; Zanotti MC; Oldani E; Grassi A; Intermesoli T; Micò C; Rossi G; Fabris P; Lambertenghi-Deliliers G; Angelucci E; Barbui T; Bassan R; Rambaldi A
Haematologica; 2007 May; 92(5):612-8. PubMed ID: 17488684
[TBL] [Abstract][Full Text] [Related]
11. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.
Hunger SP; Lu X; Devidas M; Camitta BM; Gaynon PS; Winick NJ; Reaman GH; Carroll WL
J Clin Oncol; 2012 May; 30(14):1663-9. PubMed ID: 22412151
[TBL] [Abstract][Full Text] [Related]
12. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M
Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562
[TBL] [Abstract][Full Text] [Related]
14. The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment-related mortality and not an increased relapse rate--a population-based analysis of 25 years of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
Pichler H; Reismüller B; Steiner M; Dworzak MN; Pötschger U; Urban C; Meister B; Schmitt K; Panzer-Grümayer R; Haas OA; Attarbaschi A; Mann G;
Br J Haematol; 2013 May; 161(4):556-65. PubMed ID: 23480776
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.
Matloub Y; Lindemulder S; Gaynon PS; Sather H; La M; Broxson E; Yanofsky R; Hutchinson R; Heerema NA; Nachman J; Blake M; Wells LM; Sorrell AD; Masterson M; Kelleher JF; Stork LC;
Blood; 2006 Aug; 108(4):1165-73. PubMed ID: 16609069
[TBL] [Abstract][Full Text] [Related]
16. Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol.
Hocking J; Schwarer AP; Gasiorowski R; Patil S; Avery S; Gibson J; Iland H; Ho PJ; Joshua D; Muirhead J; Lai H; Irving I
Leuk Lymphoma; 2014 Dec; 55(12):2801-7. PubMed ID: 24528220
[TBL] [Abstract][Full Text] [Related]
17. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
18. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
Stock W; La M; Sanford B; Bloomfield CD; Vardiman JW; Gaynon P; Larson RA; Nachman J; ;
Blood; 2008 Sep; 112(5):1646-54. PubMed ID: 18502832
[TBL] [Abstract][Full Text] [Related]
19. Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group.
Eckert C; Henze G; Seeger K; Hagedorn N; Mann G; Panzer-Grümayer R; Peters C; Klingebiel T; Borkhardt A; Schrappe M; Schrauder A; Escherich G; Sramkova L; Niggli F; Hitzler J; von Stackelberg A
J Clin Oncol; 2013 Jul; 31(21):2736-42. PubMed ID: 23775972
[TBL] [Abstract][Full Text] [Related]
20. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
